RESEARCHER PROFILE

Salim Yusuf

← Back to McMaster University

S

McMaster University

Acute Myocardial Infarction ResearchBlood Pressure and Hypertension StudiesHeart Failure Treatment and ManagementCardiovascular Health and Risk FactorsAtrial Fibrillation Management and Outcomes

Salim Yusuf works in Acute Myocardial Infarction Research, Blood Pressure and Hypertension Studies, Heart Failure Treatment and Management, Cardiovascular Health and Risk Factors, Atrial Fibrillation Management and Outcomes. Recorded institutional associations include Vanderbilt University, Population Health Research Institute, Hamilton Health Sciences.

2,075Publications
290,230Citations
262H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

    2004 · 12,018 citations
  2. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

    2009 · 11,218 citations
  3. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

    2010 · 3,453 citations
  4. COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

    1994 · 3,322 citations
  5. Beta blockade during and after myocardial infarction: An overview of the randomized trials

    1985 · 3,211 citations
  6. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    2003 · 2,999 citations
  7. Global Burden of Cardiovascular Diseases

    2001 · 2,972 citations
  8. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

    2005 · 2,903 citations
  9. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

    2001 · 2,809 citations
  10. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

    2003 · 2,606 citations
  11. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

    2002 · 2,578 citations
  12. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    2017 · 2,436 citations
  13. Apixaban in Patients with Atrial Fibrillation

    2011 · 2,433 citations
  14. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study

    2004 · 2,411 citations
  15. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

    2016 · 2,284 citations
  16. The burden of disease in older people and implications for health policy and practice

    2014 · 2,268 citations
  17. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

    1994 · 2,134 citations
  18. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial

    2011 · 2,125 citations
  19. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

    2000 · 2,094 citations
  20. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

    2019 · 2,000 citations
  21. ACC/AHA guidelines for coronary artery bypass graft surgery

    1999 · 1,995 citations
  22. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

    2003 · 1,889 citations
  23. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study

    2015 · 1,868 citations
  24. Interpretation of the evidence for the efficacy and safety of statin therapy

    2016 · 1,861 citations
  25. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    2003 · 1,688 citations

← Return to the university profile